Core Scientific, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 141.93 million compared to USD 121.25 million a year ago. Net loss was USD 195.69 million compared to USD 434.85 million a year ago.
For the full year, revenue was USD 502.4 million compared to USD 640.31 million a year ago. Net loss was USD 246.49 million compared to USD 2,146.32 million a year ago. Basic loss per share from continuing operations was USD 0.65 compared to USD 6.3 a year ago. Diluted loss per share from continuing operations was USD 0.65 compared to USD 6.3 a year ago.